News Articles Tagged: BCRP

Elacridar Hydrochloride: A Key Inhibitor for Preclinical Drug Development

Learn about Elacridar Hydrochloride, a crucial P-gp and BCRP inhibitor for preclinical drug development. Source this essential intermediate from a trusted China manufacturer for your research.

Investigating Drug Transport Mechanisms with Elacridar (GG918)

Learn about Elacridar (GG918, CAS 143664-11-3), a tool for studying drug transport, P-gp, and BCRP. Buy Elacridar from a reputable supplier for your research needs.

Elacridar: Your Key to Overcoming Multidrug Resistance in Cancer

Learn how Elacridar (CAS 143664-11-3), a potent P-gp and BCRP inhibitor, helps overcome multidrug resistance in cancer research. Buy high-purity Elacridar from a trusted supplier.

YHO-13177 and Drug Resistance: A Focus on BCRP/ABCG2 Mechanisms

Examine the intricate relationship between YHO-13177, BCRP/ABCG2, and drug resistance, offering insights into how this inhibitor aids in overcoming therapeutic challenges.

The Science Behind YHO-13177: Enhancing Cancer Drug Efficacy Through BCRP Inhibition

Delve into the scientific details of YHO-13177, a potent BCRP inhibitor, and understand how its mechanism of action directly contributes to improving cancer drug efficacy.

Unlocking Therapeutic Potential: YHO-13177 as a Key Pharmaceutical Intermediate

Discover how YHO-13177, a specific BCRP inhibitor, serves as a vital pharmaceutical intermediate in the development of new anticancer drugs targeting drug resistance.

The Role of YHO-13177 in Overcoming Chemoresistance: A Deep Dive for Researchers

Explore how YHO-13177, a potent BCRP inhibitor, is advancing research in overcoming cancer drug resistance and its implications for new therapeutic strategies.